e-learning
resources
Virtual 2021
07.09.2021
Advanced in vitro models for drug discovery
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Establishing ex vivo infection to influenza A virus in mouse precision cut lung slices
J. Chitty (Clayton (VIC), Australia), L. Dousha (Clayton (VIC), Australia), P. Bardin (Clayton (VIC), Australia), J. Bourke (Clayton (VIC), Australia), B. Thomas (Clayton (VIC), Australia)
Source:
Virtual Congress 2021 – Advanced in vitro models for drug discovery
Session:
Advanced in vitro models for drug discovery
Session type:
E-poster
Number:
3691
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Chitty (Clayton (VIC), Australia), L. Dousha (Clayton (VIC), Australia), P. Bardin (Clayton (VIC), Australia), J. Bourke (Clayton (VIC), Australia), B. Thomas (Clayton (VIC), Australia). Establishing ex vivo infection to influenza A virus in mouse precision cut lung slices. 3691
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Tropism and innate host responses of influenza A/H5N6 virus: an analysis of ex vivo and in vitro cultures of the human respiratory tract
Source: Eur Respir J , 49 (3) 1601710; DOI: 10.1183/13993003.01710-2016
Year: 2017
Responses to rhinovirus infection in human lung slices are reduced by rupintrivir
Source: International Congress 2016 – Immune responses in the lung
Year: 2016
Impaired viral clearance after influenza infection in IDO transgenic mice
Source: Annual Congress 2005 - Host-pathogen interaction in respiratory virus infections
Year: 2005
PP230 – Functional profiling and visualization of stromal cell dynamics in the influenza virus infected lung
Source: ERS Lung Science Conference 2021
Year: 2021
Ex vivo virus infection of HDM-sensitized lung tissue proves inadequate anti-viral immune response in small airways
Source: International Congress 2017 – Animal models of asthma and allergies
Year: 2017
Precision cut lung slices from bleomycin challenged mice – ex vivo model for testing novel therapies for lung fibrosis
Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease
Year: 2019
LSC 2013 abstract - Differential susceptibility of fetal and adult lung to respiratory syncytial virus infection and modulation by cytokine environment
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013
Role of influenza virus infection in lung fibrosis
Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease
Year: 2010
Respiratory syncytial virus in adults: relationships between viral load, symptoms and lung function in an experimental infection model
Source: Annual Congress 2008 - New diagnostic methods in viral and atypical infections
Year: 2008
Protective efficacy of virus like particles (VLPs) containing the influenza HA and/or NA in a murine model of postinfluenza bacterial pneumonia
Source: Virtual Congress 2020 – Translational science in respiratory infections
Year: 2020
LSC - 2021 - Functional profiling and visualization of stromal cell dynamics in the influenza virus infected lung
Source: Virtual Congress 2021 – Respiratory infections and bronchiectasis outcomes
Year: 2021
Clarithromycin inhibits pandemic A/H1N1/2009 influenza virus infection in human airway epithelial cells
Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections
Year: 2012
Frequency and characteristics of prolonged viral shedding of influenza A/H1N1 virus in lung transplant recipients
Source: Annual Congress 2011 - Lung transplantation
Year: 2011
Mouse models ARDS of viral etiology (influenza): the possibility of dynamic intravital assessment of lung tissue using computed tomography
Source: Virtual Congress 2021 – Assessing the impact of COVID-19 on lung function
Year: 2021
Pro-fibrotic biomarkers in ex vivo lung tissue slices: A species comparison
Source: International Congress 2017 – Lung fibrosis: basic science
Year: 2017
Viral infection drives tissue fibrosis in vitro
Source: Eur Respir Rev 2008; 17: 49-50
Year: 2008
Viral infection drives tissue fibrosis
in vitro
Source: Eur Respir J 2007; 30: Suppl. 51, 510s
Year: 2007
Fas-deficiency is deleterious in a murine model of RSV infection
Source: Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis
Year: 2009
Impact of influenza antigen specific T cell responses on severity of viral infection in humans
Source: Annual Congress 2009 - Viruses and respiratory infections: prevalence and mechanisms of infection
Year: 2009
A plant polyphenol extract reduces influenza virus infection-induced lung injury in mice
Source: Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept